Mahdizadeh Roya, Homayouni-Tabrizi Masoud, Neamati Ali, Seyedi Seyed Mohammad Reza, Tavakkol Afshari Haleh Sadat
Department of Biology, Mashhad Branch, Islamic Azad University, Mashhad, Iran.
Department of Biology, Faculty of Sciences, Ferdowsi University of Mashhad, Mashhad, Iran.
J Cell Biochem. 2019 Oct;120(10):17984-17993. doi: 10.1002/jcb.29065. Epub 2019 Jun 6.
In the present study, we aimed to synthesize and investigate the impact of zinc oxide nanoparticle (ZnONPs) on both human and murine breast cancer cell lines and define their untoxic concentrations (IC ) to clarify their apoptotic properties and introduce them as the anticancer agents.
The in vitro study was initiated by ZnONPs green synthesizing process applying the Cucumis melo inodorus rough shell extract, and verified by the transmission electron microscope, scanning electron microscopy, Fourier-transform infrared spectroscopy, and X-ray diffraction analysis. In following, the human (Michigan Cancer Foundation-7 [MCF7]) and murine (TUBO) breast cancer cell lines were cultured for taking the time and dose-dependent treatment planes by ZnONPs. Also, MCF7 cell cultures were treated by three different doses of ZnoNPs (8, 4, and 2 µg/mL) separately and prepared for genes expression (Cas-3 and Cas-8) analysis using real-time quantitative PCR method. The in vivo initiated by providing the 39 murine breast cancer models, then they were injected intraperitoneally with different doses of ZnONPs (75, 50, and 25 mg/kg) treatments. Then their collected biopsies were stained by hematoxylin and eosin to evaluate their breast cancer tissue morphology and compare with Tamoxifen anticancer properties.
The in vitro study results demonstrate a significant correlation among the expression of Cas-3 and Cas-8 genes with increasing ZnONPs concentrations. The results of 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyl tetrazolium bromide assays for the treated cancer cell lines (MCF7 and TUBO) detected a significant negative correlation among the ZnONPs concentrations and the viability of the cells.
Unlike the majority of resent studies, we found the ZnONPs as a powerful apoptosis inducer in the human cell line (MCF7) and murine (TUBO cell line and cancer model).
在本研究中,我们旨在合成并研究氧化锌纳米颗粒(ZnONPs)对人源和鼠源乳腺癌细胞系的影响,并确定其无毒浓度(IC),以阐明其凋亡特性,并将其作为抗癌剂引入。
体外研究通过应用甜瓜粗糙外壳提取物的ZnONPs绿色合成过程启动,并通过透射电子显微镜、扫描电子显微镜、傅里叶变换红外光谱和X射线衍射分析进行验证。接下来,培养人源(密歇根癌症基金会-7 [MCF7])和鼠源(TUBO)乳腺癌细胞系,以便采用ZnONPs进行时间和剂量依赖性处理。此外,MCF7细胞培养物分别用三种不同剂量的ZnONPs(8、4和2μg/mL)处理,并使用实时定量PCR方法进行基因表达(Cas-3和Cas-8)分析准备。体内研究通过建立39个鼠源乳腺癌模型启动,然后给它们腹腔注射不同剂量的ZnONPs(75、50和25mg/kg)进行处理。然后将收集的活检组织用苏木精和伊红染色,以评估其乳腺癌组织形态,并与他莫昔芬的抗癌特性进行比较。
体外研究结果表明,随着ZnONPs浓度的增加,Cas-3和Cas-8基因的表达之间存在显著相关性。对处理后的癌细胞系(MCF7和TUBO)进行的3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐检测结果显示,ZnONPs浓度与细胞活力之间存在显著负相关。
与大多数近期研究不同,我们发现ZnONPs在人源细胞系(MCF7)和鼠源(TUBO细胞系和癌症模型)中是一种强大的凋亡诱导剂。